PROPHYLACTIC USE OF CARVEDILOL TO PREVENT VENTRICULAR DYSFUNCTION IN PATIENTS WITH CANCER TREATED WITH DOXORUBICIN

被引：0
|
作者：
Kinsara, Abdulhalim [1 ]
Abuosa, Ahmed [1 ]
Elsheikh, Ayman [1 ]
Qureshi, Kahekashan [1 ]
Abrar, Mohammed [1 ]
Kholeif, Mona [1 ]
Andejani, Abdulwahab [1 ]
Ahmed, Adel [1 ]
Cleland, John [2 ]
机构：
[1] King Saud bin Abdulaziz Univ Hlth Sci, COMJ King Abdul Aziz Med City WR King, Jeddah, Saudi Arabia
[2] Imperial Coll, Natl Heart & Lung Inst, Royal Brompton & Harefield Hosp, London, England
来源：
HEART | 2018年 / 104卷
关键词：
D O I：
10.1136/heartjnl-2018-BCS.90
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
91
引用
收藏
页码：A76 / A76
页数：1
相关论文
共 50 条
  • [21] Use of high-sensitivity cardiac troponin T to predict changes in left ventricular function in cancer patients treated with doxorubicin
    Rehman, A.
    Blaes, A. H.
    Luo, X.
    Menge, M. R.
    Yee, D.
    Missov, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction
    Naccarelli, GV
    Lukas, MA
    CLINICAL CARDIOLOGY, 2005, 28 (04) : 165 - 173
  • [23] Ventricular Ectopy in Patients With Left Ventricular Dysfunction: Should It Be Treated?
    Chen, Taibo
    Koene, Ryan
    Benditt, David G.
    Lu, Fei
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (01) : 40 - 49
  • [24] Prophylactic Use of Mepitel® Film to Prevent Radiation-Induced Moist Desquamation in Cancer Patients
    Tayyib, Nahla A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [25] Ventricular-Vascular Coupling Predicts Cardiotoxicity in Breast Cancer Patients Treated With Doxorubicin or Trastuzumab
    Murthy, Ashwin
    Alpert, Craig
    Luo, Lola
    French, Benjamin
    Plappert, Ted
    Khan, Abigail
    Sutton, Martin St John
    Clark, Amy
    Gogineni, Keerthi
    Fox, Kevin
    Domchek, Susan
    DeMichele, Angela
    Carver, Joseph R.
    Ky, Bonnie
    CIRCULATION, 2013, 128 (22)
  • [26] Effect of carvedilol in patients with atrial fibrillation and left ventricular dysfunction: Analysis of the US Carvedilol Heart Failure Trials program
    Joglar, JA
    Acusta, AP
    Shusterman, NH
    Ramaswamy, K
    Kowal, RC
    Barbera, SJ
    Hamdan, MH
    Page, RL
    CIRCULATION, 2000, 102 (18) : 673 - 673
  • [27] The Effect of Carvedilol on Subclinical Left Ventricular Dysfunction after Chemotherapy of FAC Regimen in Breast Cancer Patients : An Experimental Study
    Sumantra, Gede
    Astuti, Astri
    Martanto, Erwan
    Sihite, Teddy A.
    Abdurahman, R. Maman
    Iqbal, Mohammad
    Akbar, M. Rizki
    Martha, Januar W.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)
  • [28] Carvedilol improves left ventricular diastolic dysfunction in patients with transfusion-dependent thalassemia
    Silvilairat, Suchaya
    Charoenkwan, Pimlak
    Saekho, Suwit
    Tantiworawit, Adisak
    Chattipakorn, Nipon
    ANNALS OF PEDIATRIC CARDIOLOGY, 2021, 14 (02) : 152 - 158
  • [29] Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction
    Senior, R
    Basu, S
    Kinsey, C
    Schaeffer, S
    Lahiri, A
    AMERICAN HEART JOURNAL, 1999, 137 (04) : 646 - 652
  • [30] PROPHYLACTIC TREATMENT OF CANCER - THE USE OF CHEMOTHERAPEUTIC AGENTS TO PREVENT TUMOR METASTASIS
    CRUZ, EP
    MCDONALD, GO
    COLE, WH
    SURGERY, 1956, 40 (02) : 291 - 296
12345